Search

A new study from Kenneth Offit, MD, Chief of the Clinical Genetics Service and Robert and Kate Niehaus Chair in Inherited Cancer Genomics at Memorial Sloan Kettering Cancer Center (MSK), finds that more than half of inherited cancer gene mutations in people with advanced cancer are not detected using traditional methods based on family history.

… Tuesday, September 5, 2017 Bottom Line A new study from Kenneth Offit, MD , Chief of the Clinical Genetics Service and Robert and Kate Niehaus Chair in Inherited Cancer Genomics at Memorial Sloan Kettering Cancer Center (MSK), finds that more than half of inherited cancer gene mutations in people with

In her new role, Dr. Hsu will work to diversify matriculating classes and train students to become skilled leaders as both clinicians and biomedical researchers.

… Friday, April 9, 2021 Dr. Katharine Hsu, an esteemed physician-scientist who specializes in immunology research and treatment of blood cancers , has been named director of the Tri-Institutional M.D.-Ph.D. Program , a joint program between Weill Cornell Medicine, The Rockefeller University and Memorial

When this feathered patient found her way into a New York laboratory in 1909, she changed the course of cancer science.

… Wednesday, December 27, 2017 Summary Nobel prizes aren’t awarded posthumously — or to chickens. But a case could be made that we owe our greatest cancer discoveries to one such unassuming bird. Peyton Rous wasn’t expecting a chicken to show up in his laboratory one day in 1909. But there she was, a barred

Learn how developmental biologists at MSK solved a decades-old cellular mystery. Their findings will have an immediate and lasting impact on the understanding and treatment of ciliopathies, which cause a host of medical problems and affect 1 in 2,000 people worldwide.

… Thursday, August 28, 2025 Some might say it looks like a finger. Others might see a worm. Scientists in the field often liken it to an antenna. The technical name is primary cilium. This slender, microscopic appendage juts out from the surface of most cells in the human body — and yet for many years,

Learn about a new multiple myeloma drug that can stop the disease after other treatments have failed.

… Thursday, August 24, 2023 There is good news about  multiple myeloma , a rare blood cancer that can be difficult to treat. This month, the FDA granted accelerated approval to a drug, elranatamab (Elrexfio™) for resistant forms of the disease.  “Widespread availability of elranatamab could help improve

MSK's Dr. Larry Norton, a national breast cancer expert, discusses how artificial intelligence is helping doctors.

… Monday, June 10, 2024 Artificial intelligence (AI) technology has been in the spotlight in recent months as AI chatbots and image generators have become widespread, leading to renewed conversations about the technology’s role in medicine. One of AI’s most immediate applications for patient care is to

Findings about proteins called molecular chaperones are shedding new light on possible approaches to cancer treatment.

… Thursday, November 10, 2016 Summary New research has shown that proteins called molecular chaperones work together in a communal relationship, suggesting new avenues for targeting their activity. Highlights Molecular chaperones help coordinate important activities inside cells.   Researchers are developing

Eight leading cancer centers are coming together to share genomic sequencing data, in the hope of making faster progress in curing cancer.

… Thursday, January 5, 2017 Summary A collaboration among eight leading cancer centers, including MSK, is aiming to take advantage of genomic sequencing of patient tumors to advance the field of precision oncology. On January 5, the group is announcing the release of data on nearly 19,000 cancer patients

Dr. Emmanouil Pappou urges the importance of routine cancer screenings, even during COVID-19, on the TODAY Show.

… Wednesday, November 18, 2020 Fear of COVID-19 has kept people of all ages from getting their routine cancer screenings, including mammograms and colonoscopies . However, rescheduling these vital screenings could be lifesaving. According to the American Cancer Society , more than 150,000 new cases of

Learn more about how MSK is developing new treatments for osteosarcoma and other bone cancers.

… Wednesday, September 14, 2016 Summary MSK is leading the way in osteosarcoma treatment, developing new surgical methods that enable many people to be cured and to live full, active lives. Highlights Osteosarcomas are rare tumors; two-thirds of them occur in children and young adults. They most frequently